We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Vitae Pharmaceuticals and Boehringer Ingelheim to Develop and Commercialize Novel Treatments for Diabetes and Metabolic Diseases

News   Oct 16, 2007

 
Vitae Pharmaceuticals and Boehringer Ingelheim to Develop and Commercialize Novel Treatments for Diabetes and Metabolic Diseases
 
 
Advertisement
 

RELATED ARTICLES

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

Collaborations Aim To Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

Drug Molecules Developed To Combat Deadly Drug-Resistant Enterococcus

News

Purdue University researchers have developed small molecules to combat deadly, drug-resistant enterococcus.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE